Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 204426
Company: APIL
Company: APIL
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
TAYTULLA | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | 0.02MG;1MG | CAPSULE;ORAL | Prescription | AB | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/19/2013 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204426s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/204426Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/204426_minastrin_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/204426Orig1s000SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/29/2022 | SUPPL-10 | Labeling-Package Insert, Labeling-Patient Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204426s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/204426Orig1s010ltr.pdf | |
06/26/2023 | SUPPL-9 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204426s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/204426Orig1s009ltr.pdf | |
08/09/2017 | SUPPL-7 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204426s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/204426Orig1s007ltr.pdf | |
08/19/2016 | SUPPL-4 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204426s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204426Orig1s004ltr.pdf | |
07/22/2015 | SUPPL-1 | Manufacturing (CMC) |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204426s001lbl.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
06/26/2023 | SUPPL-9 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204426s009lbl.pdf | |
04/29/2022 | SUPPL-10 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204426s010lbl.pdf | |
04/29/2022 | SUPPL-10 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204426s010lbl.pdf | |
08/09/2017 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204426s007lbl.pdf | |
08/19/2016 | SUPPL-4 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204426s004lbl.pdf | |
07/22/2015 | SUPPL-1 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204426s001lbl.pdf |
04/19/2013 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204426s000lbl.pdf |
TAYTULLA
CAPSULE;ORAL; 0.02MG;1MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
GEMMILY | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | 0.02MG;1MG | CAPSULE;ORAL | Prescription | No | AB | 213317 | XIROMED |
MERZEE | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | 0.02MG;1MG | CAPSULE;ORAL | Prescription | No | AB | 212706 | WILSHIRE PHARMS INC |
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | 0.02MG;1MG | CAPSULE;ORAL | Prescription | No | AB | 213418 | GLENMARK PHARMS LTD |
TAYTULLA | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | 0.02MG;1MG | CAPSULE;ORAL | Prescription | Yes | AB | 204426 | APIL |